5[1]Preutthipan S, Herabutya Y. Vaginal misoprostol for cervical priming before operative hysteroscopy: a randomized controlled trial. Obstet Gynecol,2000,96(6):890
6[2]Molin A. Risk of damage to the cervix in dilatation for first trimester induced abortion by suction aspiration. Gynecol Obstet Invest,1993,35:152
7[3]Ngai SW,Chan YM, Ho PC.The use of misoprostol prior to hysteroscopy in postmenopausal women. Hum Reprod,2001,16(7):1486
8Wing DA, Park MR, Paul RH. A randomized comparison of oral and intravaginal misoprostol for labor induction. Obstet Gyneco1 .2000.95(6) :905-908.
9Saxena P, Salhan S, Sarda N. Comparison between the sublingual and oral route of misoprostol for pteatmrtion cervical priming in first trimester abortions. Hum Repord. 2004, 19(1) : 77-80.
6Teng-YN, Dong RQ, Wang BJ,et al. Detenninati f mifeprist d its metabolites and their pharmacokinetics in healthy female Chinese subjects[J]. Yao Xue Xue Bao. 2011;46(10):1241-5.use effectiveness[J].Eur J Obstet Gynecol Reprod Biol. 2002,101:113-120.
7Sarkar NN. Mifepristone:bioavailability pharmacokinetics and use-effectiveness[J]. Eur J Obstet Gynecol Reprod Biol. 2002,101:113-120.
8Zieman M,Fong SK, Benowitz NL,et al. Absorption kinetics of misoprostol with oral or vaginal administration[J]. Obstet Gynecol, 1997,90:88-92.
9World Health Organization. Safe Abortion:Technical and Policy Guidance for Health Systems. Geneva:WHO; 2012.
10Raymond EG, Shannon C, Weaver MA, et alo First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review.Contraception. 2013 ,Jan;87(1):26-37.
